Results 31 to 40 of about 187,275 (304)

PATTERN OF ANTICOAGULANT THERAPY IN CARDIOEMBOLIC STROKE

Malang Neurology Journal, 2023
Background: Cardioembolic stroke is a category of ischemic stroke that manifests more severe, is prone to recurrence, and is related to a higher mortality rate than the other categories of ischemic stroke.
Reihan Achmad Reza, Lisda Amalia, Nushrotul Lailiyya Dahlan, Cep Juli, Hanna Goenawan   +4 more
doaj   +1 more source

Cerebrovascular complications and infective endocarditis. impact of available evidence on clinical outcome [PDF]

, 2018
Infective endocarditis (IE) is a life-threatening disease. Its epidemiological profile has substantially changed in recent years although 1-year mortality is still high.
De Bellis, Antonio, D’Abramo, Mizar, Frati, Giacomo, Greco, Ernesto, Iaccarino, Alessandra, Mestres, Carlos-A., Saade, Wael, Schirone, Leonardo, Sciarretta, Sebastiano   +8 more
core   +1 more source

Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study

International Journal of General Medicine, 2023
Hong Huang, Nai-Qing Hu, Jun-Yun Yang, Yu-Luan Xiang, Yuan-Zhao Zhu, Qian-Ru Du, Xue-Yan Yin, Jin-lin Lv, Li-Hua Li Department of Gerontology, The First Affiliated Hospital of Dali University, Dali, Yunnan Province, 671000, People’s Republic of ...
Huang H, Hu NQ, Yang JY, Xiang YL, Zhu YZ, Du QR, Yin XY, Lv JL, Li LH   +8 more
doaj  

Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

BMC Cardiovascular Disorders, 2020
Background It has been reported that oral anticoagulation (OAC) is underused among Chinese patients with non-valvular atrial fibrillation (NVAF). Non-vitamin K antagonist oral anticoagulants (NOAC) have been recommended by recent guidelines and have been
Ting Liu, Hui-li Yang, Lan Gu, Jie Hui, Ojo Omorogieva, Meng-xiao Ren, Xiao-hua Wang   +6 more
doaj   +1 more source

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial [PDF]

, 2019
Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage.
Al-Shahi Salman, Rustam, Baigent, Colin, Dennis, M S, Lasserson, Daniel, Murray, G D, Newby, D E, others,, Rajkumar, Chakravarthi, RESTART Collaboration,, Sandercock, P A G, Sprigg, N, Stephen, J, Sudlow, C L M, Wardlaw, J M, Werring, D J, White, P M, Whiteley, W N   +16 more
core   +1 more source

Bleeding in a COVID-19 Patient; Rectus Hematoma

Northwestern Medical Journal, 2021
Anticoagulant therapy is part of the treatment of hospitalized COVID-19 patients. Low molecular weight heparin or oral anticoagulant drugs are used in its treatment. However this approach may increase the risks of bleeding.
Kader Zeybek Aydoğan, Selman Alkan, Elif Ayşe Uçar   +2 more
doaj   +1 more source

Mechanical thrombextraction in patient with acute ischemic stroke on background of oral anticoagulant therapy [PDF]

Кардіохірургія та інтервенційна кардіологія, 2021
Thrombolytic therapy, which is a priority treatment strategy in patients with acute ischemic stroke in the first 3-4.5 hours after start of the disease, has significant limitations in case of background anticoagulant therapy. Mechanic thrombextraction is
V.О. Yarosh, V.V. Babenko, O.E. Svyrydiuk, O.J. Zharinov, O.A. Yepanchintseva, B.M. Todurov   +5 more
doaj   +1 more source

Trend of anticoagulant therapy in elderly patients with atrial fibrillation considering risks of cerebral infarction and bleeding

Scientific Reports, 2023
The introduction of direct oral anticoagulants (DOACs) has greatly changed the use of anticoagulant therapy in patients with non-valvular atrial fibrillation (Af).
Noriko Tsuji, Yoshimitsu Takahashi, Michi Sakai, Shosuke Ohtera, Junji Kaneyama, Kosai Cho, Genta Kato, Shigeru Ohtsuru, Takeo Nakayama   +8 more
doaj   +1 more source

Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review

Российский кардиологический журнал, 2023
The review article discusses the issues of anticoagulant therapy in cardiovascular patients with thrombocytopenia (TP), gives the concept of ethylenediaminetetraacetic acidand heparin-induced TP.
K. G. Pereverzeva, S. S. Yakushin, A. An. Korshikova   +2 more
doaj   +1 more source

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]

, 2018
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M, Hirsh J, Ibanez B, Mega JL, Park KW, Suh JW, Valgimigli M   +6 more
core   +3 more sources